Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04673851 · ClinicalTrials.gov registry record · NA

Horyzons: Implementation in Clinical Practice

A NA study, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
85
Enrollment target

NCT04673851 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 85 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04673851, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
85 participants
Enrollment target

Study Summary

A clinical trial investigating the feasibility and acceptability of implementing a moderated online social media platform with therapeutic content, Horyzons, as a part of care received at first-episode psychosis (FEP) clinics across North Carolina. Clients between the ages of 16 and 35 who are enrolled at one of the 4 FEP clinics or 3 UNC-affiliated STEP Clinics in North Carolina will be considered for enrollment in the trial. Cohort 1 participants will have access to the platform for 3 months and cohort 2 participants will have access to the platform for 6 months. All interventions and assessments will be completed virtually/remotely due to the global pandemic.

Interventions

  • DEVICE Horyzons USA

Trial Details

FieldValue
Enrollment Target 85 participants
Start Date 2021-01-19
Est. Completion 2023-08-31
Phase NA

What the Registry Record Tells You About NCT04673851

The ClinicalTrials.gov registry entry for NCT04673851 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Horyzons USA is the first listed.

NCT04673851 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04673851 about?

NCT04673851 is a clinical study titled "Horyzons: Implementation in Clinical Practice". A clinical trial investigating the feasibility and acceptability of implementing a moderated online social media platform with therapeutic content, Horyzons, as a part of care received at first-episode psychosis (FEP) clinics across North Carolina. Clients between the ages of 16 and 35 who are enrol...

What is the current status of trial NCT04673851?

This trial is currently completed. It is a NA study. The enrollment target is 85 participants. The study started on 2021-01-19. Estimated completion is 2023-08-31.

What interventions are being tested in trial NCT04673851?

The interventions under investigation include: Horyzons USA (DEVICE).

Who is sponsoring clinical trial NCT04673851?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.